Zhejiang Medicine Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Zhejiang Medicine stock has a consensus rating of "Buy" and an average price target of ¥17.00. The average 1-year stock price forecast is 45.18% higher than the current stock price, while the lowest is ¥15.50 (+32.37%) and the highest is ¥18.50 (+57.98%).

Price Target: ¥17.00 (+45.18%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	¥15.50	¥17.00	¥17.00	¥18.50
Change	+32.37%	+45.18%	+45.18%	+57.98%

Analyst Ratings

The average analyst rating for Zhejiang Medicine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Nov '25	Dec '25	Jan '26	Apr '26	Jun '26
Strong Buy	2	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	2	2	2	2	2

Financial Forecast

Revenue This Year

8.94B

from 8.88B

0.62%

from 8.88B

Revenue Next Year

9.70B

from 8.94B

8.51%

from 8.94B

EPS This Year

1.14

from -

EPS Next Year

n/a

from 1.14

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	9.13B	8.12B	7.79B	9.38B	8.88B	8.94B
Revenue Growth	24.60%	-11.10%	-3.96%	20.29%	-5.28%	0.62%
Gross Profit	3.60B	2.68B	2.40B	3.78B	2.90B	3.75B
Gross Margin	39.43%	33.00%	30.82%	40.37%	32.61%	42.00%
Operating Income	1.16B	489.74M	7.98M	1.29B	859.52M	1.07B
Net Income	1.05B	539.57M	429.64M	1.16B	873.38M	1.02B
EPS	-	-	-	-	-	1.14
Forward PE	12.31	15.18	13.58	10.55	13.46	10.27
Dividend / Share	0.33	0.17	0.15	0.37	0.28	0.33
Dividend Growth	-	-48.48%	-11.76%	146.67%	-24.32%	17.86%
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue	2026	2027	2028
High	8.9B
Avg	8.9B
Low	8.9B

Revenue Growth

Revenue Growth	2026	2027	2028
High	0.6%
Avg	0.6%
Low	0.6%

EPS Forecast

EPS	2026	2027	2028
High	1.14
Avg	1.14
Low	1.14

EPS Growth

EPS Growth	2026	2027	2028
High	-5.8%
Avg	-5.8%
Low	-5.8%